Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00955786
What this trial is testing

Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorsLymphoma
Cylene Pharmaceuticals 48
Testing effectiveness (Phase 2)Study completedNCT00127855
What this trial is testing

Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 409
Testing effectiveness (Phase 2)Study completedNCT03352076
What this trial is testing

Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing Laparoscopy

Who this might be right for
Endometriosis
Viramal Limited 30
Testing effectiveness (Phase 2)Study completedNCT05593042
What this trial is testing

Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile

Who this might be right for
COVID-19Vaccines
Pontificia Universidad Catolica de Chile 551
Post-approval studies (Phase 4)Study completedNCT01054222
What this trial is testing

Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder

Who this might be right for
Urinary Bladder, Overactive
Pfizer 31
Large-scale testing (Phase 3)Study completedNCT01984697
What this trial is testing

A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)

Who this might be right for
Human Papillomavirus Infection
Merck Sharp & Dohme LLC 1,518
Testing effectiveness (Phase 2)Study completedNCT02623725
What this trial is testing

Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 251
Large-scale testing (Phase 3)Study completedNCT00709969
What this trial is testing

Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
Novartis 310
Large-scale testing (Phase 3)Study completedNCT02127970
What this trial is testing

Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Who this might be right for
AbscessWound InfectionSurgical Site Infection+1 more
Durata Therapeutics Inc., an affiliate of Allergan plc 698
Early research (Phase 1)UnknownNCT06237491
What this trial is testing

The Safety and Dosimetry Study of 177Lu-LNC1003 Injection

Who this might be right for
Metastatic Castration-resistant Prostate Cancer, mCRPC
Yantai LNC Biotechnology Singapore PTE. LTD. 12
Not applicableStudy completedNCT00002394
What this trial is testing

Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment

Who this might be right for
Candidiasis, OralHIV Infections
Novartis 30
Testing effectiveness (Phase 2)Study completedNCT00170456
What this trial is testing

Phase II Study of Range and Schedule of rPA Doses

Who this might be right for
Prevention of Bacillus Anthracis (Anthrax) Infection
PharmAthene UK Limited 415
Large-scale testing (Phase 3)Study completedNCT00002723
What this trial is testing

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 390
Testing effectiveness (Phase 2)Study completedNCT05997264
What this trial is testing

Anthrax AV7909 Boost Evaluation Study

Who this might be right for
Anthrax
Biomedical Advanced Research and Development Authority 220
Post-approval studies (Phase 4)Study completedNCT04929093
What this trial is testing

Novel Dose Adjustment Schedule for Late Injection in SCIT in AR

Who this might be right for
Allergic RhinitisImmunotherapy
Beijing Tongren Hospital 102
Post-approval studies (Phase 4)Study completedNCT00806494
What this trial is testing

UK Study Assessing Flexible Dose Fesoterodine in Adults

Who this might be right for
Urinary Bladder, Overactive
Pfizer 331
Post-approval studies (Phase 4)Study completedNCT01235403
What this trial is testing

Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure

Who this might be right for
Partial Epilepsies
UCB Pharma 100
Early research (Phase 1)Study completedNCT01938638
What this trial is testing

Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Bayer 80
Testing effectiveness (Phase 2)Study completedNCT03527355
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine

Who this might be right for
Typhoid
International Vaccine Institute 285
Early research (Phase 1)Study completedNCT02325050
What this trial is testing

A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 164
Next Page